What’s Guggenheim Updates View on AtaiBeckley Inc (ATAI)?

AtaiBeckley Inc (NASDAQ:ATAI) is among the must-buy penny stocks to invest in now. The stock has gained more than 180% over the past 12 months. On April 17, Guggenheim lifted its price target on AtaiBeckley Inc (NASDAQ:ATAI) to $16 from $11 and reiterated a Buy rating on the stock. Guggenheim’s new price target suggests significant upside potential given ATAI stock currently trades at about $4.

What’s Guggenheim Updates View on AtaiBeckley Inc (ATAI)?

Guggenheim cited AtaiBeckley’s solid financial position for its renewed bullish view on the stock. According to the firm, AtaiBeckley has enough funds to last it through pivotal readouts in early 2029.

In its Q4 2025 report released on March 6, AtaiBeckley said it closed the year with $220.7 million in cash, cash equivalents, and short-term securities. This increased from $72.3 million at the end of 2024. The company’s management went on to say that they expected the cash to be enough to fund operations into 2029.

AtaiBeckley is underway with several trial programs. These include BPL-003, which enters a Phase 3 trial in Q2 2026. AtaiBeckley is developing BPL-003 as a treatment for severe depression. According to Guggenheim, the AtaiBeckley management sees BPL-003 as presenting a paradigm shift in the treatment of severe depression. The compound’s short-acting profile is seen as a major differentiator with regard to patient preference, clinical site preference, and clinic economics.

AtaiBeckley Inc (NASDAQ:ATAI) is a pharmaceutical company focused on developing therapies for mental health conditions. The company was founded in 2018 and is based in Berlin, Germany. AtaiBeckley is one of the companies developing psychedelic drugs.

While we acknowledge the risk and potential of ATAI as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ATAI and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 8 Must-Buy Small Cap Stocks to Buy and 10 Best Medical AI Stocks to Buy Now.

Disclosure: None. Follow Insider Monkey on Google News.